2008;23:147 51. 1203. Angouras DC, Anagnostopoulos CE, Chamogeorgakis TP, et al. Post- operative and long-term outcome of patients with chronic obstructive pulmonary disease undergoing coronary artery bypass grafting. Ann Thorac Surg. 2010;89:1112 8. 1204. Fuster RG, Argudo JA, Albarova OG, et al. Prognostic value of chronic obstructive pulmonary disease in coronary artery bypass grafting. Eur J Cardiothorac Surg. 2006;29:202 9. 1205. Canver CC, Nichols RD, Kroncke GM. influence of age-specific lung function on survival after coronary bypass. Ann Thorac Surg. 1998; 66:144 7. 1206. Bapoje SR, Whitaker JF, Schulz T, et al. Preoperative evaluation of the patient with pulmonary disease. Chest. 2007;132:1637 45. 1207. Bingol H, Cingoz F, Balkan A, et al. The effect of oral prednisolone with chronic obstructive pulmonary disease undergoing coronary artery bypass surgery. J Card Surg. 2005;20:252 6. 1208. Starobin D, Kramer MR, Garty M, et al. Morbidity associated with systemic corticosteroid preparation for coronary artery bypass grafting in patients with chronic obstructive pulmonary disease: a case control study. J Cardiothorac Surg. 2007;2:25. 1209. Staton GW, Williams WH, Mahoney EM, et al. Pulmonary outcomes of off-pump vs on-pump coronary artery bypass surgery in a ran- domized trial. Chest. 2005;127:892 901. 1210. Liu JY, Birkmeyer NJ, Sanders JH, et al., Northern New England Cardiovascular Disease Study Group. Risks of morbidity and mortality in dialysis patients undergoing coronary artery bypass surgery. Circu- lation. 2000;102:2973 7. 1211. Lloyd-Jones D. Heart Disease and Stroke Statistics. Circulation. 2010; 121 78. 1212. United States Renal Data System: National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases. USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease. Bethesda, Md: 2009. NIH Publication No. 09-3176. 1213. Anderson RJ, O Brien M, MaWhinney S, et al. 